Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 8 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Avicena Group, Inc. | 1,020,242 | reported | 28 Dec 2006 | tx 1−185,000 |
| aTYR PHARMA INC | 779,143 | reported | 27 May 2026 | tx 68+5,901,519−4,722,392 |
| ALKERMES INC | 360,600 | reported | 15 Jun 2007 | tx 10+70,000−16,635 |
| Sirtris Pharmaceuticals, Inc. | 20,834 | reported | 30 Nov 2007 | tx 8+293,451−1,438,288 |
| 9,000 |
| reported |
| 01 Jul 2019 |
| tx 96+556,997−469,761 |
| Forte Biosciences, Inc. | 7,500 | reported | 04 Oct 2019 | tx 13+96,855−240,316 |
| REPLIGEN CORP | 5,000 | reported | 14 Jun 2007 | tx 7+50,000−3,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | PURCHASE | aTYR PHARMA INC | 100,000 | 0.50 USD | |
| 11 May 2026 | GRANT_AWARD | aTYR PHARMA INC | 50,000 | 0.00 USD | deriv |
| 08 Oct 2025 | PURCHASE | aTYR PHARMA INC | 682,001 | 0.90 USD | first after silence |
| 09 Oct 2025 | PURCHASE | aTYR PHARMA INC | 317,999 | 0.94 USD | |
| 01 May 2025 | GRANT_AWARD | aTYR PHARMA INC | 50,000 | 0.00 USD | deriv |
| 22 Jul 2024 | PURCHASE | aTYR PHARMA INC | 41,052 | 1.74 USD | first after silence |
| 23 Jul 2024 | PURCHASE | aTYR PHARMA INC | 6,648 | 1.82 USD | |
| 24 Jul 2024 | PURCHASE | aTYR PHARMA INC | 52,300 | 1.93 USD | |
| 22 May 2024 | GRANT_AWARD | aTYR PHARMA INC | 24,000 | 0.00 USD | deriv |
| 17 May 2023 | GRANT_AWARD | aTYR PHARMA INC | 12,000 | 0.00 USD | deriv |
| 10 May 2023 | PURCHASE | aTYR PHARMA INC | 200,000 | 2.25 USD | first after silence |
| 26 Apr 2023 | EXERCISE | aTYR PHARMA INC | 6,000 | — | |
| 26 Apr 2023 | EXERCISE | aTYR PHARMA INC | 6,000 | 0.00 USD | deriv |
| 26 Apr 2022 | GRANT_AWARD | aTYR PHARMA INC | 6,000 | 0.00 USD | deriv |
| 20 Sept 2021 | GIFT | aTYR PHARMA INC | 250,000 | 0.00 USD | |
| 20 Sept 2021 | PURCHASE | aTYR PHARMA INC | 250,000 | 8.00 USD | |
| 20 Sept 2021 | GIFT | aTYR PHARMA INC | 250,000 | 0.00 USD | |
| 18 May 2021 | PURCHASE | aTYR PHARMA INC | 50,000 | 3.98 USD | first after silence |
| 28 Apr 2021 | GRANT_AWARD | aTYR PHARMA INC | 1,428 | 0.00 USD | deriv |
| 20 May 2020 | SALE | aTYR PHARMA INC | 8,447 | 3.64 USD | |
| 06 May 2020 | GRANT_AWARD | aTYR PHARMA INC | 1,428 | 0.00 USD | deriv |
| 10 Feb 2020 | PURCHASE | aTYR PHARMA INC | 254,000 | 4.25 USD | first after silence |
| 04 Oct 2019 | GRANT_AWARD | Forte Biosciences, Inc. | 7,500 | 0.00 USD | deriv |
| 01 Jul 2019 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 9,000 | 0.00 USD | deriv |
| 29 May 2019 | GRANT_AWARD | Forte Biosciences, Inc. | 20,000 | 0.00 USD | deriv |
7 purchases reported after at least 12 months of silence — most recent on 08 Oct 2025.